Organization Overview
Alternative names
90y-dota-epratuzumab (1 trial)
allogeneic stem cells (1 trial)
anastrozole (arimidex) (1 trial)
bevacizumab (avastin) (1 trial)
durvalumab (imfinzi) (1 trial)
everolimus (zortress) (1 trial)
fludarabine (fludara) (1 trial)
Adenocarcinoma (Phase 3)
Astrocytoma (Phase 1)
Breast Neoplasms (Phase 3)
Carcinoma (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Central Nervous System Neoplasms (Phase 1)
Colorectal Neoplasms (Phase 3)
Disease Progression (Phase 2)
Esophageal Neoplasms (Phase 2)
Gastrointestinal Neoplasms (Phase 2)
Glioblastoma (Phase 1)
Glioma (Phase 1)
Head and Neck Neoplasms (Phase 3)
Hypoxia (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphoid (Phase 2)
Lung Neoplasms (Phase 2)
Multiple Myeloma (Phase 2)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Nervous System Neoplasms (Phase 1)
Neuralgia (Phase 3)
Neurotoxicity Syndromes (Phase 2)
Prostatic Neoplasms (Phase 3)
Rectal Neoplasms (Phase 3)
Recurrence (Phase 3)
Small Cell Lung Carcinoma (Phase 2)
Stomach Neoplasms (Phase 2)
Triple Negative Breast Neoplasms (Phase 2)